HIV Tutoring By Alaina Darby.

Slides:



Advertisements
Similar presentations
Case 2: 40-year-old Woman with Long-standing HIV Infection
Advertisements

ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
Summary of ARV prescribing guidelines in London These slides summarise the recommendations by the London HIV Consortium for prescribing antiretrovirals.
WHO Guidelines for treatment monitoring Nathan Ford Dept of HIV/AIDS World Health Organization.
Michelle Moorhouse 26 Mar 2015
KITSO AIDS Training Program
Introduction to ARV therapy
HIV opportunistic infections and HIV treatment Sabrina Assoumou, MD Section of Infectious Diseases.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Switch to DRV/r monotherapy  MONOI  MONET  PROTEA  DRV600.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 ARV Drug Resistance HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Comparison of NRTI combinations  ZDV/3TC vs TDF + FTC –Study 934  ABC/3TC vs TDF/FTC –HEAT Study –ACTG A5202 Study –ASSERT Study  FTC/TDF vs FTC/TAF.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Comparison of NNRTI vs NNRTI  ENCORE  EFV vs RPV –ECHO-THRIVE –STAR  EFV vs ETR –SENSE.
Switch to DRV/r monotherapy  MONOI  MONET  PROTEA  DRV600.
Comparison of NNRTI vs PI/r  EFV vs LPV/r vs EFV + LPV/r –A5142 –Mexican Study  NVP vs ATV/r –ARTEN  EFV vs ATV/r –A5202.
ANTEPARTUM CARE. Pregnant Women Who Are ARV Naive (1)  Pregnant women with HIV infection should receive standard clinical, immunologic, and virologic.
Switch PI/R to ETR  Etraswitch. Etraswitch Study: Switch PI/r to ETR Continuation of current PI/R + 2 NRTI N = 21 N = 22 ETR 400 mg QD* + 2 NRTI  Design.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
WHO 2013 Consultative Meeting Tawanna Hotel October 15, 2013.
Management of the Treatment-Experienced Patient Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents April 2015 AETC NRC Slide Set.
Switch NNRTI to NNRTI  Switch EFV to ETR –CNS toxicity study –Patient’s preference study.
Novel Antiretroviral Studies and Strategies
Switch to PI/r monotherapy
HIV Part Dos By Alaina Darby.
Comprehensive Guideline Summary
Antiretroviral Therapy (ART)
Optimizing Antiretorviral Therapy for Long-Term HIV Care
Dolutegravir plus Rilpivirine as Maintenance Dual Therapy SWORD-1 and SWORD- 2: Design
Switch to PI/r + 3TC vs PI/r monotherapy
Comprehensive Guideline Summary
Pharmacokinetics: HIV Drugs
ART 101 Successful HIV treatment usually consists of at least three drugs from two different “classes” of ARV drugs There are now six classes of ARV drugs:
ARV-trial.com Switch to LPV/r + RAL KITE Study 1.
Learning Objectives By the end of the session, participants will:
Pharmacokinetics: HIV Drugs
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Adult Guidelines Pretoria, Saturday 17th February 2018
Switch ABC/3TC to TAF/FTC
New regimen for $75 a year New pricing agreement will speed up access to generic, dolutegravir (DTG)-based fixed dose combinations (FDCs)  HIV positive.
Switch to DTG + 3TC ASPIRE Study.
Switch to DTG-containing regimen
Switch to DRV/r + 3TC DUAL Study.
Charles Gilks HIV Department, WHO
Comparison of NNRTI vs NNRTI
Comparison of NRTI combinations
Switch to E/C/F/TAF + DRV
Michael S. Saag, MD Professor of Medicine
Switch to DRV/r monotherapy
Comparison of NNRTI vs PI/r
Comparison of NRTI combinations
Comparison of INSTI vs EFV
Antiretroviral therapy and its complications
ARV-trial.com Switch to DRV/r + RPV PROBE Study 1.
Comparison of NNRTI vs PI/r
Comparison of NRTI combinations
Switch to RAL-containing regimen
CASO CLINICO Il paziente naϊve con resistenze al basale.
Comparison of NRTI combinations
ARV-trial.com Switch to DTG/ABC/3TC STRIIVING NEAT
Diagnosis and Management of HIV-2 in Adults
Farinaz khan Dept of FCM
ARV-trial.com Switch to FTC + ddI + EFV ALIZE 1.
Comparison of NNRTI vs NNRTI
Selecting an Initial Antiretroviral Therapy (ART) Regimen
Comparison of PI vs PI ATV vs ATV/r BMS 089
Presentation transcript:

HIV Tutoring By Alaina Darby

Genotype resistance testing Plasma HIV RNA Complete blood count (CBC) JD is a 22 yo WM who is suspected to have contracted HIV. Which of the following tests would be most necessary? Genotype resistance testing Plasma HIV RNA Complete blood count (CBC) Fasting blood glucose b

Reduce HIV-associated morbidity Preserve immunologic function JD is a 22 yo WM who is suspected to have contracted HIV. He has now been diagnosed. Which of the following would not be a primary goal for treating his HIV? Reduce HIV-associated morbidity Preserve immunologic function Prevent transmission Minimize adverse effects d

HIV viral load below detection limit Lower CD4 count JD is a 22 yo WM who is suspected to have contracted HIV. He has now been diagnosed. Which of the following would not predict therapeutic success? HIV viral load below detection limit Lower CD4 count High potency ARV regimen Low baseline viremia b

All with HIV should start ART JD is a 22 yo WM who is suspected to have contracted HIV. He has now been diagnosed. Weighing the concerns of starting ART, which of the following would indicate the need to start ART? Low CD4 Homosexual lifestyle High HIV load All with HIV should start ART d

Resistance development Non-adherence JD is a 22 yo WM who is suspected to have contracted HIV. He has now been diagnosed. Which of the following would not be a concern with him taking ART? Immune suppression Quality of life Resistance development Non-adherence a

Which of the following medication classes is the backbone of ART? PI NNRTI NRTI INSTI c

Which of the following medication classes is properly matched with its drug? PI - EFV NNRTI - ATV NRTI - ABC INSTI - TDF c

Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 BR is a 44 yo WF who is starting ART. Her labs are listed on the left. Which of the following NRTI backbones should she most likely receive? ABC/3Tc FTC/TDF FTC/3Tc ABC/TDF Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 a

Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 BR is a 44 yo WF who is starting ART. Her labs are listed on the left. You decide to start her on ABC/3Tc. What should you test before starting this NRTI combination as opposed to another NRTI combo? LFTs HLA-B Blood glucose Serum lipids Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 b

Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 BR is a 44 yo WF who is starting ART. Her labs are listed on the left. You find that she has a history of night terrors. What is your recommendation now? ABC/3Tc FTC/TDF FTC/3Tc ABC/TDF Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 b… and dose adjust

Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 BR is a 44 yo WF who is starting ART. Her labs are listed on the left. You find that she has a history of night terrors. You start her on FTC/TDF. What is a lab value that you would need to recheck based on ADR’s for both of these drugs? LFTs HLA-B Blood glucose Serum lipids Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 a

What would not be a reason to prescribe FTC/TDF over ABC/3Tc? History of adherence issues Previous hematological problems Previous rash with carbamazepine History of sleep disturbances b

JD has a h/o neuropsychosis and kidney stones JD has a h/o neuropsychosis and kidney stones. Which of the following adjunctive medications to TDF/FTC should he receive? ATV DRV RPV EFV Labs: HIV RNA: 80,000 CD4: 300 Na+: 138 Cl-: 105 K+: 5.2 HCO3: 25 FBG: 108 b

Which of the following should be taken on an empty stomach? ATV DRV RPV EFV d

Which of the following would be least preferred for someone who is also taking a PPI? ATV DRV RPV EFV A and c

Which of the following would be best if a patient is taking carbamazepine for seizures? ATV DRV RPV EFV a

RP has a history of STEMI and adherence issues RP has a history of STEMI and adherence issues. He is currently taking omeprazole. Which of the following would be the preferred PI for him? ATV DRV LPV NFV b

The doctor wants to start JW on a statin but is worried about the increased risk of rhabdo given his current ART therapy. What agent is he likely taking? DTG EVG RAL RTG c

The doctor wants to start JW on a statin but is worried about the increased risk of rhabdo given his current ART therapy. What agent is he likely taking? DTG EVG RAL RTG c

Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 Remember her? BR is a 44 yo WF who is starting ART. Her labs are listed on the left. Which of the following should not be used in her? Atripla Complera Stribild Triumeq Labs: HIV RNA: 75,000 CD4: 450 LFT: WNL CrCl: 38 c

ADRs/contraindications to remember: ABC: hypersensitivity rash (HLA testing), sleep d/o FTC/3Tc/TDF: HBV exacerbation TDF: bone marrow issues, bone density EFV: neuropsych d/o RPV: not for high RNA/low CD4 LPV: heart issues RAL: rhabdo c

Drug class generalities: NRTIs: hepatomegaly, Cushing's NNRTIs (-vir-): resistance PIs (-vir): hyperglycemia, bleeding, hyperlipidemia INSTIs (-tegravir): absorption impaired by antacids c

Preferred: 2 NRTIs plus INSTI or NNRTI or PI + r/c c

Your patient is HLA positive. Which would you not use? Atripla Complera Stribild Triumeq d

What would be a potential option in a patient that is HLA positive and already has low bone density and bone marrow defects? LPV/r + 3TC DRV/r + 3TC ATV/c + RAL ATV/c + 3TC a

Efavirenz is the fav for TB but not pregnancy or CNS! Just a little trick! Efavirenz is the fav for TB but not pregnancy or CNS! a

More side effects and considerations… TDF: bone, kidney EFV: brain, methadone ABC, LPV/r: cardiac a